Short and Mid-term Efficacy of Device Closure of Patent Foramen Ovale for Treating the Patients With Patent Foramen Ovale Combining Cryptogenic Stroke and Transient Ischemic Attack
10.3969/j.issn.1000-3614.2017.04.016
- VernacularTitle:经导管封堵术治疗卵圆孔未闭合并隐匿性卒中或短暂性缺血发作的近中期疗效观察
- Author:
Haojia HUANG
;
Haibo HU
;
Zhongying XU
;
Gejun ZHANG
;
Xiangbin PAN
;
Hong ZHENG
;
Jinglin JIN
;
Jianhua LV
;
Shiguo LI
;
Chaowu YAN
;
Liang XU
;
Junyi WAN
;
Qiong LIU
;
Shiliang JIANG
- Keywords:
Cardiac defect;
congenifal;
Stroke;
Septal occluder deice
- From:
Chinese Circulation Journal
2017;32(4):377-379
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the short and mid-term efficacy of device closure of patent foramen ovale (PFO) for treating the patients with PFO combining cryptogenic stroke (CS) and transient ischemic attack (TIA). Methods: A total of 56 PFO patients with CS and TIA receiving device closure in our hospital from 2009-05 to 2015-12 were retrospectively studied. Transthoracic echocardiography (TTE), electrocardiogram (ECG), chest X-ray were examined at 24h, 1 month, 3 and 6 months after theoperation; telephone visit was conducted every 6 months thereafter. Results: There were 54/56 PFO patients combining CS and 2 combining TIA; 53 (94.6%)patients received PFO occluder from Starway medical technology. Aspirin was used for 6 months after the operation. The patients were followed-up for the average of (34.67±23.24) months. No body suffered from post-operative stroke and TIA; no residual shunt was observed. Conclusion: The short and mid-term efficacy of device closure has been satisfactory for treating the patients with PFO combining CS and TIA; its overall clinical value should be further investigated in large population and long-term study.
